Introduction
In recent years, implant devices have been required in medical fields. For example, insulin delivery devices are widely utilized for the release and control of insulin in the treatment of diabetes mellitus, this method is also known as continuous subcutaneous insulin infusion therapy. 1, 2 Such devices are useful as an alternative to multiple daily injections of insulin, and they allow for intensive insulin therapy when used in conjunction with blood glucose monitoring. However, equipment installation and daily removal of the device is troublesome for patients. Recently, small, implantable drug-delivery devices that enable drug diffusion in vivo [3] [4] [5] [6] have been developed. Although these devices are expected to improve the quality of life for patients, electric sources are indispensable for mechanical devices that administer liquid in the devices, and so using them permanently is extremely difficult.
On the other hand, we previously developed a small scale, spherical shaped bio-micropump actuated by cardiomyocytes that requires only a chemical energy source. 7 This pump was developed based on the integrated chemistry technology, a part of which is often referred to either as a micro total analysis system (μ-TAS) or as a lab-on-a-chip. Such technology creates extremely efficient analytical devices that exploit the advantages of micron dimensions. [8] [9] [10] [11] In particular, the incorporation of cells into micro-chemical systems is useful to achieve practical prototypical micro-devices, because the scale of the fluidic microvolume is roughly proportional to the sizes and processing capabilities of living cells. [12] [13] [14] [15] [16] [17] [18] [19] While most of these devices use cellular biochemical functions, we proposed to utilize the mechanical function of spontaneously and synchronously beating cardiomyocytes in microfluidic devices, 20 and we developed a cardiomyocyte-based pump. 7 By utilizing this pump, one can expect to achieve a novel, permanently actuated implant device fueled by glucose in the blood. Such a pump could automatically sense the glucose concentration and release insulin at an appropriate concentration if pancreatic β cells were cultured inside the device. This kind of pump can be utilized for analysis of circulation systems in vitro.
In order for us to construct such a cardiomyocyte pump-based implant device, however, an important issue must be addressed. Cardiomyocytes must be cultured confluently inside a microspace to realize self-irrigation energy supplying system by cardiomyocytes, because cardiomyocytes must continuously touch flow produced by themselves as a real heart. Although cardiomyocyte culture in microchips designed to pump fluid was previously reported, 21 cardiomyocytes were cultured on only one side of the chamber. To fully exploit cardiomyocyte performance, spherical or cylindrical structures are better, as we demonstrated previously. 7 However, cardiomyocytes are difficult to culture confluently in a closed three-dimensional space because their numbers do not increase and because they require more energy during culturing than do other cells due to their beating motion. Furthermore, even other kinds of cells that increase easily have not yet been cultured on a spherical structure. So, cardiomyocytes' confluent culture in a cylindrical microchannel is an important step for cardiomyocyte culture inside a hollow spherical structure.
The objective of this study is to establish confluent culture conditions of cardiomyocytes in a cylindrical microchannel. To realize this, we introduced cardiomyocytes 2 times, before and after turning over a microchip, and we investigated optimum conditions for cardiomyocyte culture. We established a confluent cardiomyocyte culture method using an 800-μm diameter cylindrical microchannel in this report. This was realized by introducing cardiomyocytes 2 times before and after turning over a microchip. The optimum condition was starting the flowing medium 2.0 h after seeding and flowing the medium at 1.0 μL/min. By applying this technology to a cardiomyocyte-based spherical heart pump device, one may develop self-fluid regulated devices that could be applied for implantable or circulation analysis device on a chip. 
Establishment of a Confluent

Notes
Experimental
Experimental set up for cardiomyocyte confluent culture in a microchip
The experimental setup for the investigation of cardiomyocyte culture in a microchip is shown in Fig. 1 . A continuous flow system was designed and constructed using microfluidic techniques based on a cell culture system in a glass microchip. Briefly, the flow rates of the liquids were controlled by syringes (Terumo) and micro syringe pumps (KD Scientific) in the withdraw mode to prevent air bubbles. All liquids (cell adhesion protein solution, cell suspension, reagents, and medium) were introduced into the microchannel by this method.
Fabrication of a PDMS microchip
The following procedure was used to fabricate a PDMS microchip with cylindrical microchannels. Firstly, a PDMS prepolymer (Silpot 184 W/C, Dow Corning Asia, Japan) was prepared by mixing PDMS base with a curing agent in a 10:1 ratio by weight, degassing, 22 and then pouring the solution over a glass slide (76 × 22 mm rectangular shape, Matsunami) to a 5-mm thickness. This covered slide was then heated on a hotplate at 100 C for 1 h to solidify the PDMS prepolymer. Next, a 800-μm diameter piece of cylindrical aluminum wire was placed on the sheet as a mold for a microchannel. Again, the PDMS prepolymer was poured over the PDMS sheet with a wire to 5 mm thickness, then solidified by heating on a hot plate at 100 C for 1 h. The PDMS sheet was then removed from the glass slide, and the wire was pulled to make a cylindrical microchannel. Inlet and outlet holes were made on the edge of the microchannel by using a milling machine (No. 16000, Proxxon). Finally, the edge of the microchannel was closed by applying PDMS prepolymer there and solidifying it. Polytetrafluoroethylene (PTFE) capillaries (inlet length, 10 cm; outlet length, 30 cm; i.d., 0.3 mm; o.d., 0.5 mm) were connected to the microchip via the inlet and outlet holes, and the connecting region was glued to prevent leakage.
Preparation of neonatal rat cardiomyocytes
Primary neonatal rat cardiomyocytes were prepared by the following procedures. 23 Briefly, ventricles from neonatal Wistar rats (CREA Japan) were digested at 37 C in Hank's balanced salt solution (Sigma) containing collagenase (class II, Worthington Biochemical). Isolated cells were suspended in the culture medium consisting of 6% FBS, 40% Medium 199 (Invitrogen), 0.2% penicillin-streptomycin solution, 2.7 mM glucose, and 54% balanced salt solution containing 116 mM NaCl, 1.0 mM NaH2PO4, 1.18 mM KCl, 0.87 mM CaCl2, and 26.2 mM NaHCO3. The primary cell suspension was prepared at a cell density of 2 × 10 6 /ml. This experiment was conducted in accordance with the relevant laws and with the rules approved by the institutional committee.
Cardiomyocyte culture in a PDMS microchip
Before cell introduction, the PDMS microchannel was washed with 70% ethanol for disinfection and then immersed for 1 h in 50 μg/mL fibronectin solution in phosphate buffered saline (PBS) at 37 C to promote cardiomyocyte attachment. After this modification, the microchannel and the capillaries were filled with the cardiomyocyte culture medium described in the previous section.
A cardiomyocyte suspension was prepared and introduced into the microchannel at a flow rate of 2.0 μL/min. After cardiomyocytes were introduced, the capillary was pinched by a clip to stop the flow in the microchannel. The system was then incubated at 37 C in 5% CO2 to allow cardiomyocytes to attach to the microchannel wall during a pre-determined period. After that, the microchannel was washed with medium at 2.0 μL/min. Next, the microchip was turned over, and again the cardiomyocyte solution was introduced and incubated under the same conditions used for the first cell introduction and attachment. Finally, the medium was supplied in the microchannel using a micro syringe pump at a pre-determined flow rate.
Cardiomyocytes cultured in a microchannel were observed using a fluorescent microscope (IX71, Olympus) and the images were recorded by a color, high vision CMOS camera (1920 × 1080 pixels, IK-HR1D/X.AVCio/MTN, Mitani Corporation). The beat frequency of the cardiomyocytes was also measured using a movie recorded by this system.
Nuclei staining
Nuclei in cardiomyocytes were stained and their fluorescence was observed according to the following procedures. Nuclei of cardiomyocytes were stained by Hoechst 33342 (Invitrogen). Hoechst solution (100 mg/mL) was introduced into the microchannel. The microchannel was then washed with fresh medium to wash out the Hoechst solution. Microchannels were observed in situ using a fluorescent microscope (IX71, Olympus) with an objective lens. For nuclei observation, the excitation and emission wavelength were 350 and 465 nm, respectively (using a DAPI filter set).
Results and Discussion
Design of a microchip
We report here the optimized conditions for confluent cardiomyocyte culture in a cylindrical microchannel. We utilized PDMS as the material of a microchip; this was the material used for a previously developed cardiomyocyte pump. 7 Also, a relatively large (800 μm diameter) channel was used, because around 1 mm is a practical size limitation in fabricating a spherical or tubular hollow structure with a thin PDMS membrane. 7 The shape of the channel was cylindrical, because that is close to a spherical structure but it is easier to observe. The fabricated microchip is shown in Fig. 2(A) . Two cylindrical microchannels (800 μm diameter) were fabricated successfully on the microchip. The total length of the microchannel was 5 cm, and the total volume was 25 μL.
Optimization of incubation time before medium perfusion
Normally, cells attach to the surface within 1 -2 h. If medium is introduced before attachment, cells are flushed away. However, if the incubation time is too long in a closed space, enough oxygen and energy cannot be supplied to cells, so they Fig. 1 An experimental set up. Liquid in a microtube is introduced into the microchannel using a micro syringe pump in the withdraw mode. Cardiomyocytes are cultured confluently in a cylindrical microchannel.
eventually die. Cardiomyocytes in particular require more oxygen and energy than other cells due to their beating motion. Therefore, investigation of optimal incubation times after cell introduction is important. In this experiment, cells were introduced 2 times before and after turning over the microchip in order to attach cells to both the top and bottom surfaces of the cylindrical microchannel.
This procedure was necessary because cardiomyocytes do not increase in number, and so they must be confluent initially. The first and second incubation times were the same, specifically: 0.5, 1.0, 2.0 and 3.0 h. The result is shown in Fig. 2(B) . After that, the microchannel was washed with the medium. Each cell density was counted before and after washing. Cell attachment rates were estimated by dividing the cell density after washing by the density before washing as done in a previous report. 22 The graph indicated that the optimum time was 2.0 h. This result is the same as that found for culturing other cells such as endothelial cells 22 or hepatocytes. 24 This means that the normal cell incubation time before pumping medium (2.0 h) was long enough to allow an energy supply for cardiomyocytes in this microchannel.
Optimization of flow rate for cell culture
The flow rate during culture is also a very important factor. Under a low flow rate, cells cannot obtain enough oxygen and energy from the medium to survive. Under a high flow rate, cells are detached from the microchannel surface because of the high shear stress. In particular, cardiomyocytes require plenty of energy due to their beating motion, and the number of detached cells must be as small as possible to maintain the confluent state, because cardiomyocytes do not increase in number, as described above.
After 2.0 h incubation of cardiomyocytes as optimized above, the medium was introduced. After 3 days from the starting culture, the nuclei of cells were stained, and cell attachment rates were estimated by dividing the cell density after 3 days by the density just before the medium started flowing. The culture flow rates were determined as 0.1, 1.0, 2.0 and 10.0 μL/min. The result is shown in Fig. 2(C) . The graph indicates that the optimum flow rate was 1.0 μL/min and that the cell attachment rate reached over 95%, almost confluent. In this flow condition, the time to replace the entire channel volume is 25 min. Furthermore, the spontaneous and simultaneous beating motion of cardiomyocytes was observed, the beat frequency was measured as 0.8 Hz, which is comparable to that of cardiomyocytes normally cultured on a culture dish. 25, 26 Cardiomyocytes cultured on the bottom surface of the microchannel under these optimum conditions are shown in Fig. 2(D) . Cardiomyocytes were confluent in both the upper and the bottom parts of the channel. This is the first demonstration of confluent and simultaneously beating cardiomyocyte culture in a microchannel.
Conclusions
In this report, confluent culture conditions for cardiomyocytes in a cylindrical microchannel were established. This was realized by introducing cardiomyocytes 2 times before and after turning over a microchip using a PDMS microchip with an 800-μm diameter cylindrical microchannel. The optimum condition was starting flowing medium 2.0 h after seeding and flowing the medium at 1.0 μL/min.
This study is one of several fundamental investigations directed to create cardiomyocyte pumps that can provide internal power for an implant device such as an insulin pump. To achieve this, one must culture cardiomyocytes and islets of Langerhans in a spherical device, and fluid pumping must be demonstrated in combination with flexible check valves. 27 Moreover, fabrication methods for microdevices must be improved for high reproducibility. By solving these issues, researchers will develop an implantable, self-regulated insulin delivery device in the future. Furthermore, combining with previously developed mimic vascular systems, 28 a model of the circulatory system in vitro can be constructed, and it would be applied for cardiovascular cells or tissue physiological analysis. 
